Nu-Med Plus, Inc. (OTCPK:NUMD) entered into a letter of intent to acquire Your Space, Inc. on May 15, 2023. Nu-Med Plus shall issue up to 600,000 shares of Preferred Stock to the holders of the Merging Entity's capital stock (the "Merger Consideration"). Nu-Med Plus will assume all liabilities of the Merging Entity, including any liabilities arising after the Closing Date under any assigned contracts of the Merging Entity.

The consummation of the Transaction is subject to due diligence, the negotiation and the execution of the Definitive Agreement, including exhibits and schedules thereto, in form and substance satisfactory to each of the Merging Entity, the Surviving Entity and their respective counsel. Nu-Med Plus will require its stockholders to enter into a lock-up agreement with respect to its common stock for a period of not less than 180 days from the date of closing upon the merger. Nu-Med Plus, Inc. and its stockholders will be required to comply Rule 144 promulgated by the Securities and Exchange Commission .